<?xml version="1.0" encoding="UTF-8"?>
<ref id="R54">
 <label>54.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Burger</surname>
    <given-names>JA</given-names>
   </name>
   <name>
    <surname>Barr</surname>
    <given-names>PM</given-names>
   </name>
   <name>
    <surname>Robak</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study</article-title>. 
  <source>
   <italic toggle="yes">Leukemia.</italic>
  </source>
  <year>2020</year>;
  <volume>34</volume>:
  <fpage>787</fpage>â€“
  <lpage>798</lpage>.
  <pub-id pub-id-type="pmid">31628428</pub-id>
 </mixed-citation>
</ref>
